Harrow Health, Inc.
HROW · NASDAQ
Bulios Fair Price
$40.99
18.9% upside
Trenutna cena
$34.48
Po podatkih Bulios Fair Price je delnica HROW trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Harrow Health, Inc. is a pharmaceutical company primarily focused on providing affordable and innovative drugs and healthcare products. The company specializes in the development and commercialization of pharmaceuticals and medical devices in the fields of ophthalmology, dermatology, and neurology. Their portfolio includes a wide range of therapeutic products, including generics, branded drugs, and medical devices, aimed at treating various health conditions and diseases. Harrow Health, Inc. focuses on providing affordable and quality medications for patients and strengthening its position in the pharmaceuticals and healthcare products market.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mark L. Baum
Employees
373
Headquarters
Nashville
Prihajajoči dogodki
Earnings
Upcoming earnings report